Found: 12
Select item for more details and to access through your institution.
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate.
- Published in:
- Annals of Internal Medicine, 1979, v. 91, n. 6, p. 819, doi. 10.7326/0003-4819-91-6-819
- By:
- Publication type:
- Article
Clinical effects and toxicity of interleukin-2 in patients with cancer.
- Published in:
- 1986
- By:
- Publication type:
- journal article
High-grade soft tissue sarcomas of the extremities.
- Published in:
- 1986
- By:
- Publication type:
- journal article
A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities.
- Published in:
- 1983
- By:
- Publication type:
- journal article
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
- Published in:
- Cancer (0008543X), 1981, v. 47, n. 7, p. 1746, doi. 10.1002/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4
- By:
- Publication type:
- Article
Clinical and immunologic studies of disseminated BCG infection.
- Published in:
- 1978
- By:
- Publication type:
- journal article
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.
- Published in:
- 1998
- By:
- Publication type:
- journal article
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL-2.
- Published in:
- 1995
- By:
- Publication type:
- journal article
The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article